Fereydoun Firouz is a Pioneer at ARTIS Ventures. He is the former Chairman and CEO of Stallergenes Greer, a global biopharma company. Prior to Stallergenes Greer, he co-founded and was managing partner of Gurnet Point Capital, an investor in life sciences companies, in addition to serving as managing director of Waypoint Capital Inc, a Swiss-based family office.

 

As a Pioneer, Fereydoun brings a wealth of Biopharma and leadership experience to the ARTIS portfolio after a 25+ year career at Biopharma company Merck Serono, which he ultimately led as President and CEO of the US business EMD Serono.

FF.png
Fereydoun Firouz

PIONEER